385 related articles for article (PubMed ID: 11108952)
21. The molecular basis of Marfan syndrome.
Maslen CL; Glanville RW
DNA Cell Biol; 1993 Sep; 12(7):561-72. PubMed ID: 8397814
[TBL] [Abstract][Full Text] [Related]
22. Steered molecular dynamic simulations reveal Marfan syndrome mutations disrupt fibrillin-1 cbEGF domain mechanosensitive calcium binding.
Haller SJ; Roitberg AE; Dudley AT
Sci Rep; 2020 Oct; 10(1):16844. PubMed ID: 33033378
[TBL] [Abstract][Full Text] [Related]
23. Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites.
Ono RN; Sengle G; Charbonneau NL; Carlberg V; Bächinger HP; Sasaki T; Lee-Arteaga S; Zilberberg L; Rifkin DB; Ramirez F; Chu ML; Sakai LY
J Biol Chem; 2009 Jun; 284(25):16872-16881. PubMed ID: 19349279
[TBL] [Abstract][Full Text] [Related]
24. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
Lemaire R; Bayle J; Lafyatis R
Curr Opin Rheumatol; 2006 Nov; 18(6):582-7. PubMed ID: 17053502
[TBL] [Abstract][Full Text] [Related]
25. Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization.
Lee SS; Knott V; Jovanović J; Harlos K; Grimes JM; Choulier L; Mardon HJ; Stuart DI; Handford PA
Structure; 2004 Apr; 12(4):717-29. PubMed ID: 15062093
[TBL] [Abstract][Full Text] [Related]
26. The fibrillins.
Ramirez F; Pereira L
Int J Biochem Cell Biol; 1999 Feb; 31(2):255-9. PubMed ID: 10216958
[TBL] [Abstract][Full Text] [Related]
27. Fibrillin: from domain structure to supramolecular assembly.
Handford PA; Downing AK; Reinhardt DP; Sakai LY
Matrix Biol; 2000 Nov; 19(6):457-70. PubMed ID: 11068200
[TBL] [Abstract][Full Text] [Related]
28. Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils.
Lin G; Tiedemann K; Vollbrandt T; Peters H; Batge B; Brinckmann J; Reinhardt DP
J Biol Chem; 2002 Dec; 277(52):50795-804. PubMed ID: 12399449
[TBL] [Abstract][Full Text] [Related]
29. Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuria.
Hutchinson S; Aplin RT; Webb H; Kettle S; Timmermans J; Boers GH; Handford PA
J Mol Biol; 2005 Feb; 346(3):833-44. PubMed ID: 15713466
[TBL] [Abstract][Full Text] [Related]
30. Marfan syndrome: new clues to genotype-phenotype correlations.
Ramirez F; Gayraud B; Pereira L
Ann Med; 1999 Jun; 31(3):202-7. PubMed ID: 10442675
[TBL] [Abstract][Full Text] [Related]
31. Fibrillin-1 misfolding and disease.
Whiteman P; Hutchinson S; Handford PA
Antioxid Redox Signal; 2006; 8(3-4):338-46. PubMed ID: 16677079
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of fibrillin-1 cDNA clones in a human fibroblast cell line that assembles microfibrils.
Kettle S; Card CM; Hutchinson S; Sykes B; Handford PA
Int J Biochem Cell Biol; 2000 Feb; 32(2):201-14. PubMed ID: 10687954
[TBL] [Abstract][Full Text] [Related]
33. The fibrillin-Marfan syndrome connection.
Ramirez F; Pereira L; Zhang H; Lee B
Bioessays; 1993 Sep; 15(9):589-94. PubMed ID: 8240311
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.
Dietz HC; Pyeritz RE
Hum Mol Genet; 1995; 4 Spec No():1799-809. PubMed ID: 8541880
[TBL] [Abstract][Full Text] [Related]
35. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders.
Downing AK; Knott V; Werner JM; Cardy CM; Campbell ID; Handford PA
Cell; 1996 May; 85(4):597-605. PubMed ID: 8653794
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetics of Marfan syndrome.
Boileau C; Jondeau G; Mizuguchi T; Matsumoto N
Curr Opin Cardiol; 2005 May; 20(3):194-200. PubMed ID: 15861007
[TBL] [Abstract][Full Text] [Related]
37. Fibrillin degradation by matrix metalloproteinases: identification of amino- and carboxy-terminal cleavage sites.
Hindson VJ; Ashworth JL; Rock MJ; Cunliffe S; Shuttleworth CA; Kielty CM
FEBS Lett; 1999 Jun; 452(3):195-8. PubMed ID: 10386589
[TBL] [Abstract][Full Text] [Related]
38. Fibrillin microfibrils.
Kielty CM; Sherratt MJ; Marson A; Baldock C
Adv Protein Chem; 2005; 70():405-36. PubMed ID: 15837522
[TBL] [Abstract][Full Text] [Related]
39. A Gly --> Ser change causes defective folding in vitro of calcium-binding epidermal growth factor-like domains from factor IX and fibrillin-1.
Whiteman P; Downing AK; Smallridge R; Winship PR; Handford PA
J Biol Chem; 1998 Apr; 273(14):7807-13. PubMed ID: 9525872
[TBL] [Abstract][Full Text] [Related]
40. Fibrillin: monomers and microfibrils.
Sakai LY; Keene DR
Methods Enzymol; 1994; 245():29-52. PubMed ID: 7760739
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
